Side-by-side comparison of AI visibility scores, market position, and capabilities
Criteo is a global commerce media platform enabling retailers and brands to run performance advertising across open internet and retail media networks. Public CRTO on Nasdaq.
Criteo is a Paris and New York-based commerce media company publicly traded on Nasdaq under the ticker CRTO that evolved from a retargeting advertising pioneer into a broad commerce media platform connecting retail media networks, brands, and publishers across the open internet. Founded in 2005, Criteo's original product — dynamic retargeting that served personalized product ads to shoppers who had visited a retailer's website — established the company as a leader in performance advertising for e-commerce and drove its 2013 Nasdaq IPO. The company subsequently transformed its platform in response to the deprecation of third-party cookies and the rise of retail media, positioning Criteo's first-party data graph and retailer partnerships as the foundation for a privacy-compliant, commerce-intent-driven advertising ecosystem that addresses post-cookie advertising performance challenges.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.